Prediabetes management often emphasizes weight loss, but a long-term follow-up study found that for some older adults, ...

NEW YORK, May 21 (Reuters) - Eli Lilly said on Thursday that its experimental drug retatrutide helped patients diagnosed with obesity lose more than 28% of their weight over a year and a half in a key ...

By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) - Lower prices for weight-loss pills from Novo Nordisk ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from ...

FDA approval of Eli Lilly’s weight-loss pill on April 1 shows the fast-changing landscape for weight loss, obesity ...

Three out of four adults who begin taking a GLP-1 medication stop using it within a year.

Lilly’s weight loss pill gained approval in April 2026, around three months after Novo Nordisk gained the same accolade for oral Wegovy.

Nearly half of patients who got a high dose of Eli Lilly & Co.’s next-generation obesity shot lost the equivalent weight of ...

NEW YORK, May 21 () - Eli Lilly said on Thursday that its experimental drug retatrutide helped patients diagnosed with ...

The findings from two clinical trials suggest that a lower dose of GLP-1 drugs, or switching to an oral pill like Foundayo, can help to maintain weight loss.

Columbus Clinic Adds Structured Medical Weight Loss Workflows Columbus, United States - May 20, 2026 / 1513 Wellness ...